|
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma - (Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO ) The Company submitted a supplemental New Drug Application (sNDA) to the U.S....
(usually chemotherapy) and aims to improve the initial effect of an induction therapy. First line consolidation treatment with Zevalin offers clear benefits for patients in improving the quality of their response and therefore extending their remission period" said Professor Tim Illidge, a...
Celgene Limited expressed disappointment at the advice given by the Scottish Medicines Consortium (SMC) that Revlimid® (lenalidomide) is not recommended for use within the NHS in Scotland for the treatment of multiple myeloma, on the grounds of cost effectiveness. It is estimated that, on average...
The American Society of Hematology (ASH) is proud to announce the 2008 recipients of its Trainee Research Awards. This year 40 medical students, undergraduates, and residents will each receive $4,000 to conduct research on blood and blood-related diseases through this program, which is designed...
Oncology Partners, a medical billing and practice management firm serving oncology practitioners, today announced implementation of its billing and collections ... ... Oncology Partners, a medical billing and practice management firm serving oncology practitioners, today...
News source: Business Wire ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. , today announced it has appointed Ivan N. Rich, Ph.D., to its advisory board. Dr. Rich's experience as the founder, chairman and C.E.O. of HemoGenix(R)...
Focus on the World Blood Processing Supplies and Equipment Markets ... LONDON, UNITED KINGDOM, May 5 / MARKET WIRE/ -- World Blood Processing Supplies and Equipment Markets t-Markets.html This report analyzes the worldwide markets for Blood Processing Supplies and...
As China faces mounting questions regarding its food and drug safety, the country's minister of health, Dr. Chen Zhu, is set to receive an honorary degree this week from the Mount Sinai School of Medicine. Dr. Chen, 55, a hematologist who began his career as a medic in rural China, will travel to...
A new study, 'Levetiracetam and bleeding disorders,' is now available. "Six studies were conducted in healthy male volunteers to evaluate the effect of levetiracetam on bleeding time. In three open-label studies, a single dose of levetiracetam (250, 500, or 1000 mg, respectively) was administered...
compared to $0.46 for fiscal 2007. o Cash, cash equivalents and short- and long-term investments as of March 31, 2008 of $59.7 million, compared to $45.2 million as of March 31, 2007. Quarterly Results: For the fiscal quarter ended March 31, 2008, Abaxis reported revenues...
